Product
scAAv9/JeT-GAN
1 clinical trial
2 indications
Indication
Giant Axonal NeuropathyIndication
Gene TransferClinical trial
A Phase I Study of Intrathecal Administration of scAAV9/JeT-GAN for the Treatment of Giant Axonal NeuropathyStatus: Active (not recruiting), Estimated PCD: 2030-06-30